Indivior Pharmaceuticals, Inc 6-K, filed Mar 4, 2024
Indivior Pharmaceuticals, Inc. (INDV)
6-K
2024-03-04
For: 2024-03-04
View Original
Added on
July 07, 2026
About this 6-K
Indivior Pharmaceuticals, Inc filed this 6-K on March 4, 2024.
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
________________________
Washington, D.C. 20549
_____________________
FORM 6-K
_____________________
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
Date: March 4, 2024
Commission File Number: 001-37835
________________________________________
Indivior PLC
________________________________________
10710 Midlothian Turnpike, Suite 125
North Chesterfield, Virginia 23235
(Address of principal executive office)
_______________________________
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(7): ☐
|
|
EXHIBIT INDEX
|
Exhibit No.
|
Description of Exhibit
|
|
99.1
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
Indivior PLC
|
|
Date: March 4,
2024
|
/s/
Kathryn Hudson
|
|
|
Name:
Kathryn Hudson
|
|
|
Title:
Company Secretary
|
Exhibit 99.1
INDIVIOR PLC (THE 'COMPANY')
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
The relevant notification set out below is provided in accordance
with the requirements of the UK Market Abuse
Regulation.
The Company announces that it was notified on March 1, 2024, that
the following Persons discharging managerial responsibilities
('PDMR') exercised an option over ordinary shares of $0.50 each in
the Company ('Shares'). The number of shares exercised are outlined
below.
|
Name
|
Date of Grant
|
Number of Shares
|
Exercise Priceper Share
|
Date of Exercise
|
|
Kathryn
Hudson
|
December 4, 2020
|
1,875
|
£4.80
|
March 1, 2024
|
|
Hillel
West
|
December 4, 2020
|
2,250
|
£4.80
|
March 1, 2024
|
Following the transactions, Kathryn Hudson retained her interest in
the shares and holds a beneficial interest in 32,858 Shares. On
March 1, 2024, Hillel West sold the shares resulting from the
option exercise and holds a beneficial interest in 27,733
Shares.
Kathryn Hudson
Company Secretary
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
|
||
|
a)
|
Name
|
Kathryn
Hudson
|
|
|
|
2
|
Reason for the notification
|
|
||
|
a)
|
Position/status
|
PDMR -
Company Secretary
|
|
|
|
b)
|
Initial notification /Amendment
|
Initial
notification
|
|
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
||
|
a)
|
Name
|
Indivior
PLC
|
|
|
|
b)
|
LEI
|
213800V3NCQTY7IED471
|
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
||
|
a)
|
Description of the financial instrument, type of
instrument
Identification
code
|
Ordinary Shares of US$0.50
GB00BN4HT335
|
|
|
|
b)
|
Nature of the transaction
|
Exercise
of a share option under the ShareSave Plan
|
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
|
£4.80
|
1875
|
|||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A
|
|
|
|
e)
|
Date of the transaction
|
March
1, 2024
|
|
|
|
f)
|
Place of the transaction
|
Outside
a trading venue
|
|
|
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
|
||
|
a)
|
Name
|
Hillel
West
|
|
|
|
2
|
Reason for the notification
|
|
||
|
a)
|
Position/status
|
PDMR -
Chief Manufacturing and Supply Officer
|
|
|
|
b)
|
Initial notification /Amendment
|
Initial
notification
|
|
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
||
|
a)
|
Name
|
Indivior
PLC
|
|
|
|
b)
|
LEI
|
213800V3NCQTY7IED471
|
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
||
|
a)
|
Description of the financial instrument, type of
instrument
Identification
code
|
Ordinary Shares of US$0.50
GB00BN4HT335
|
|
|
|
b)
|
Nature of the transaction
|
Exercise
of a share option under the ShareSave Plan and sale of the
resulting shares
|
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volumes(s)
|
|
|
1. £4.80
|
2,250
|
|||
|
2. £17.61
|
2,250
|
|||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A
|
|
|
|
e)
|
Date of the transaction
|
March
1, 2024
|
|
|
|
f)
|
Place of the transaction
|
1.
Outside a trading venue
2.
London Stock Exchange (XLON)
|
|
|
This notification is made in accordance with the requirements of
the Market Abuse Regulation.
Indivior PLC's Legal Entity Identifier code is
213800V3NCQTY7IED471